Toward Equitable Innovation in Health and Medicine A Framework (2023) / Chapter Skim
Currently Skimming:
Appendix A: Information Sources and Methods
Appendix A: Information Sources and Methods
Pages 157-162
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 157... ...
COMMISSION COMPOSITION The National Academies of Sciences, Engineering, and Medicine and the National Academy of Medicine appointed a committee of 19 experts to undertake the statement of task. The committee was composed of members with expertise in such areas as biomedical research and development in academia and industry; health equity and justice; bioethics of emerging science and technology; governance, policy, and innovation; technology assessment, economics, and behavioral economics; and community engagement.
|
From page 158... ...
Materials developed by CESTI articulated essential elements and ethical principles to inform governance of emerging science, technology, and innovation, drawing on preparation and analysis of three case study discussion papers, in the areas of regenerative medicine, neurotechnology and noninvasive neuromodulation, and telehealth and mobile health. Each case study opened with hypothetical vignettes to illustrate potential ethical issues, identified key stakeholders and how governance developed within and across sectors, and concluded with a "visioning" section on possible evolutionary trajectories the example may take that would need to be accounted for in a governance system.
|
From page 159... ...
• Opening presentation and panel discussion on decision making by investor com munities (October 2022) At a fifth meeting in January 2023, the committee discussed the conclusions and recommendations presented in this report and prepared its draft report for external review following National Academies policies and procedures.
|
From page 160... ...
• What approaches or incentives are most useful for improving governance of emerg ing science, technology, and innovation to mitigate potential risks, enhance societal benefits, and increase alignment of emerging technologies with ethical principles? • Are there practical ways to enhance coordination among potential actors and at various stages in the emerging S&T life cycle?
|
From page 161... ...
Glenn Cohen, Harvard University Robert Cook-Deegan, Arizona State University Regina Dugan, CEO, Wellcome Leap Kadija Ferryman, Johns Hopkins University Michelle Groman, Greenwall Foundation Andrea Hodgson, Schmidt Futures Priti Krishtel, Initiative for Medicines, Access & Knowledge (I-MAK) Katharine Ku, Wilson Sonsini Goodrich & Rosati Holly Fernandez Lynch, University of Pennsylvania Laura Maher, Siegel Family Endowment on behalf of the Public Interest Technology Infrastructure Fund Aisling McMahon, Maynooth University, Ireland Bradley Malin, Vanderbilt University Lori Melichar, Robert Wood Johnson Foundation Michelle Shevin, Ford Foundation Susan Song, Gordon and Betty Moore Foundation Sabriya Stukes, IndieBioNY Herman Taylor, Morehouse School of Medicine Kush Varshney, IBM Research Alice Xiang, Sony AI Ruqaiijah Yearby, St.
|
From page 162... ...
Does the technology pose risks to an individual's personal privacy? Is there a mechanism for stakeholder engagement and incorporation of public interests and values?
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.